Sonoma Pharmaceuticals (SNOA) Research & Development (2010 - 2025)

Sonoma Pharmaceuticals' Research & Development history runs 16 years deep, the most recent figure standing at $557000.0 for Q4 2025.

• In Q4 2025, Research & Development rose 30.44% year-over-year to $557000.0; the TTM figure through Dec 2025 stood at $2.1 million (up 17.94% YoY), while the FY2025 annual figure was $1.8 million, down 3.05% from the prior year.
• Research & Development was $557000.0 for Q4 2025 at Sonoma Pharmaceuticals, down from $575000.0 in the prior quarter.
• In the past five years, Research & Development ranged from a high of $601000.0 in Q4 2023 to a low of $4000.0 in Q1 2022.
• Historically, Research & Development has averaged $330105.3 across 5 years, with a median of $409000.0 in 2024.
• The sharpest annual moves came in 2022 and 2023: Research & Development plunged 96.92% in 2022, then jumped 4925.0% in 2023.
• A 5-year view of Research & Development shows it stood at $26000.0 in 2021, then soared by 669.23% to $200000.0 in 2022, then jumped by 200.5% to $601000.0 in 2023, then slipped by 28.95% to $427000.0 in 2024, then soared by 30.44% to $557000.0 in 2025.
• The last three Research & Development figures came in at $557000.0 (Q4 2025), $575000.0 (Q3 2025), and $594000.0 (Q2 2025), per Business Quant data.